La biología y el tratamiento de la ceguera con células madre

Des cellulles souches pour soigner la vision

Restoring vision with stem cells

Intellectual property

STEMAXON​'s cumulative IP, starting with the only proven human sporadic AD model (PCT) and AD-cascade related compounds (PCT) greatly advance drug development and testing in the treatment and early stage diagnostics of Alzheimer’ disease.



STEMAXON's Legal partners are Fasken Martineau.



In the News:

​​FOLLOW US ON LINKEDIN

STEMAXON is a Canadian biotechnology company located in Montréal which specializes in stem cell technology.

STEMAXON to validate the technology of iPSC differentiation into photoreceptor cells for cell therapy applications

Stem Cell Advance Brings Vision Repair in Sight

ADVANCED RESEARCH FOR LIFE

El trasplante de fotorreceptores llega para curar la degeneración macular

​​The Biology of Treating Blindness with Stem Cells

MEMBER OF BIOQUÉBEC

STEMAXON has been nominated as a finalist for the ADRIQ's ''26th INNOVATION AWARD''

FOR ALL THE LATEST NEWS, PLEASE VISIT OUR LINKEDIN PAGE

Stem Cells: Regeneration Methods for the Visual System

who we are